Jitendra N. Doshi, Chief Executive Officer at CARACO PHARMACEUTICAL LABORATORIES LTD (CPD), sold 21,100 shares at $6.04 ($128K) on 2010-07-27, disclosed to the SEC on 2010-07-29.
Scheduled sale ($128k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.04 | 10,246 | $62K | 48.5% |
| 2 | $6.05 | 400 | $2K | 1.9% |
| 3 | $6.06 | 600 | $4K | 2.9% |
| 4 | $6.07 | 854 | $5K | 4.1% |
| 5 | $6.04 | 5,700 | $34K | 27.0% |
| 6 | $6.04 | 1,000 |
| $6K |
| 4.7% |
| 7 | $6.05 | 300 | $2K | 1.4% |
| 8 | $6.06 | 1,200 | $7K | 5.7% |
| 9 | $6.07 | 400 | $2K | 1.9% |
| 10 | $6.08 | 300 | $2K | 1.4% |
| 11 | $6.10 | 100 | $610 | 0.5% |
| Total | $6.04 avg | 21,100 | $128K | 100% |
| Filing → |
| CPD | SELL | 2007-11-21 | $73K | — | Filing → |
| CPD | SELL | 2007-11-19 | $6K | — | Filing → |
| CPD | SELL | 2007-11-02 | $47K | — | Filing → |